DelveInsight's Gastroesophageal Reflux Disease Market Insights report includes a comprehensive understanding of current treatment practices, gastroesophageal reflux disease emerging drugs, market ...
The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do not achieve ...
Unmatched diagnostic expertise, delivering over 12,000 GI physiology tests each year and operating the only independent UKAS accredited GI physiology service in the country. This means participants ...
A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...
Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.
Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...
Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and ...
A recent article from Mayo Clinic President and CEO Gianrico Farrugia, M.D., offers a compelling glimpse of what that future ...
More than 370,000 insured patients in the US underwent kidney stone surgery in 2019, highlighting the importance of the 2026 AUA guidelines.
Once-weekly semaglutide significantly reduces hospital admissions and total hospital stay in patients with cardiovascular disease and obesity.